Home >
Specialties > IVD Test Reagent/Kits, Molecular Assay, Infection, Bacteria, Mycobacterium tuberculosis
IVD Test Reagent/Kits, Molecular Assay, Infection, Bacteria, Mycobacterium tuberculosis
Definition : Molecular assay reagents intended to identify Mycobacterium tuberculosis, a species of slow-growing bacterium of the genus Mycobacterium, family Mycobacteriaceae, by detecting specific genetic information of the nucleic acid of the target bacteria. These bacteria are the etiologic agent of human tuberculosis.
Entry Terms : "Tuberculosis Diagnostic Reagents" , "Tuberculosis Mycobacteria Detection/Identification Reagents" , "Mycobacteria tuberculosis Identification Reagents" , "Mycobacteria tuberculosis Reagents, Identification" , "Mycobacterium tuberculosis Detection/Identification Reagents" , "Mycobacterium Reagents, Identification" , "Mycobacterium Species Detection/Identification Reagents" , "Reagents, Molecular Assay, Infection, Bacteria, Mycobacterium tuberculosis"
UMDC code : 19564
Filters
| | Alere Inc Company Type: Parent Alere Inc., a global healthcare company, announced a new partnership with Population Services International as part of the "Make (+) Positive More Positive Campaign. |  | | Calbiotech Inc Company Type: Parent Calbiotech specialty is in custom design of immunoassay products for human and animal applications. |  | | InBios International Inc Company Type: Parent InBios International, Inc. is a medical diagnostic company that specializes in developing, manufacturing and marketing medical diagnostic tests for the detection of infectious diseases. Since its inception in 1996, InBios has developed proprietary technologies useful in the development of rapid and ELISA based immunodiagnostic assays. It has also licensed antigens from major corporations and research organizations from which a number of its assays have been developed. |  | | Oxford Immunotec Inc Company Type: Parent |  | | ZeptoMetrix Corp Company Type: Parent ZeptoMetrix is a privately held company formed in 1999 to serve the diagnostic and pharmaceutical research products industries. In 2003, the company acquired the BioClinical Partners division of Impath Corporation and a highly complementary and successful partnership was formed. |  | |
|